Medplus Health Services Capital Structure Change

Medplus Health Services Board Meeting Date

MedPlus Health Services scheduled a board meeting for 6 November 2026 to consider a share buy-back. The trading window for designated persons closes from 30 October 2026.

Medplus Health Services Earnings Call Transcript: Key Takeaways

Medplus reported Q2 revenue of ₹2,037.1 Cr with 21.3% pharmacy growth, but EBITDA margins were hit by state-mandated wage hikes.

Call

Guides 10% growth

Medplus Health Services Share Pledge

Catalyst Trusteeship pledged 34,00,000 Medplus Health Services shares (2.83%) as debenture collateral. Total encumbered shares rose to 2,41,50,400 (20.10% of capital).

Medplus Health Services Investor Presentation: Key Takeaways

Q2 FY27 revenue ₹2,037cr (+21.3% YoY), operating EBITDA ₹98cr (4.8% margin), reported PAT ₹56cr (+1% YoY). Store expansion continues; no explicit guidance given.

Medplus Health Services Employee Stock Options

MedPlus allotted 19,095 equity shares to employees on exercise of ESOP 2021 options. Paid-up capital rises to Rs 24.03 Crore.

Medplus Health Services Q2 FY27 Results: Net Profit ₹56.1 Cr, Up 1.1% YoY

Medplus Health Services Ltd reported revenue from operations of ₹2,037 Cr (+21.3% YoY) and net profit of ₹56.1 Cr (+1.1% YoY) for Q2 FY27.

Key figure

Net profit ₹56.1 Cr · +1.1% YoY

Bharat Forge Capital Structure Change

Bharat Forge completed a Rs 240 crore rights-issue investment in its wholly owned subsidiary KSSL. KSSL in turn invested Rs 163 crore in its subsidiary AEL.

Value

₹240.0 Cr

Delhivery Capital Structure Change

Delhivery will infuse up to Rs.36 Crore into its wholly owned subsidiary DFDPL in tranches. The funds support the subsidiary's fintech distribution business for logistics participants.

Value

₹36.00 Cr

Execution

In one or more tranches, as per DFDPL's business requirement, up to Rs.36 Crore.

Man Infraconstruction Capital Structure Change

Man Infraconstruction bought back 67,000 equity shares on October 30, 2026 at an average price of Rs.106.93. Total buyback so far is 1,04,17,000 shares.

Value

₹0.72 Cr

Blue Chip Tex Industries Capital Structure Change

Blue Chip Tex Industries approved a tender-offer buy-back of 2,50,000 equity shares at Rs.130 per share, up to Rs.3.25 Crore. The record date is set for November 25 to December 2, 2026.

Value

₹3.25 Cr

Execution

Record/book closure 25-11-2026 to 02-12-2026; AGM/EGM/postal ballot date 02-12-2026

PB Fintech Capital Structure Change

HDFC Mutual Fund schemes raised their PB Fintech stake by 2.02% to 7.03% via open-market purchases. The acquisition was dated 28 October 2026.

Amerise Biosciences Capital Structure Change

Snehjeev Ventures and persons acting in concert acquired 18,342 Amerise Biosciences shares in the open market on 28 Oct 2026. Their holding crossed 13%, reaching 13.02%.